DFX Intelligence

Data Factory

VentureFirminstitutional vcexempt_reporting_adviser

Windham Venture Partners

Venture Capital

New York, NY

We focus on advances in medical technology and digital health to change the face of healthcare.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:46541f13-5b07-48cb-966f-da73a652a6f2

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 12:29 AM UTC and rebuilt at most every 15 minutes.

Relationships: 64
Dated events: 40
On other graphs: 0
Observed: Sep 12, 2026 to Sep 17, 2026
49 observations

Across DFX

This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 9
Vintages: 2020 to 2023
Reported GAV: $109Mgross asset value on Form ADV; never dry powder
Funds with fundraising evidence: 1derived
Investments: 37
Portfolio companies: 37
Investments, 12m: 37
Partner-attributed: 0
People: 17
Investment professionals: 6derived
Co-investors: 0derived
LP relationships: 0
Stated sectors: healthcareas stated by the firm
Latest Form D: Nov 13, 2025
Latest ADV filing: Jul 17, 2025
Website: windhamvp.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV
Windham Life Sciences Partners IV, L.P.	2023	Fundraising	$30.8M	n/a
Windham Life Sciences Partners II Annex Fund, L.P.	2022	Active deployment	n/a	$7.5M
Windham Life Sciences Partners III, L.P.	2020	Mature	n/a	$55.6M
Wlsp Coinvestment, LLC	2020	Mature	n/a	$7.6M
Windham-Gs Investment, LLC	2020	Wound down	n/a	$2.0M
Windham-Mc Investment I, LLC	n/a	Wound down	n/a	$3.9M
Windham-Crv Investment I, LLC	n/a	Unknown	n/a	$2.3M
Windham Life Sciences Partners, L.P.	n/a	Unknown	n/a	$8.5M
Windham Life Sciences Partners II, L.P.	n/a	Unknown	n/a	$27.8M

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
fore.bio	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
rxware.io	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Novocure	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Aytubio	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Painteq	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Altoneuroscience	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Andros	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Blueprinthealth	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Cartiva	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
ChromaCode, Inc.	CA	n/a	n/a	n/a	Unknown	Sep 13, 2026
Alcon	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Clevercarehealthplan	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Controlrad	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Coravin	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Cureatr	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
INITIATE Ventures	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Dotscorp	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Glysens	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Stryker	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Locemia	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Mc10	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Nebula	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Neuspera	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Neotract	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026
Personalgenome	n/a	n/a	n/a	n/a	Unknown	Sep 13, 2026

Co-investors

pairs come only from shared rounds and listings

Investor	Co-investor	Shared deals	Shared companies	Last observed	Strength
Asset Management Ventures, LLC	Windham Venture Partners	2	2	Sep 16, 2026	Recurring
Portfolia Venture Management, LLC	Windham Venture Partners	2	2	Sep 16, 2026	Recurring
Menlo Ventures	Windham Venture Partners	1	1	Sep 13, 2026	One time
Windham Venture Partners	Lightstone Ventures	1	1	Sep 13, 2026	One time
NEA: New Enterprise Associates	Windham Venture Partners	1	1	Sep 13, 2026	One time
Windham Venture Partners	Accelmed Partners II Management, LLC	1	1	Sep 16, 2026	One time
Windham Venture Partners	Riverwalk Capital	1	1	Sep 16, 2026	One time
Windham Venture Partners	Excel Venture Management	1	1	Sep 16, 2026	One time
Vivo Capital, LLC	Windham Venture Partners	1	1	Sep 16, 2026	One time
Windham Venture Partners	Union Square Ventures	1	1	Sep 16, 2026	One time
Windham Venture Partners	Mitsui & Co. Global Investment, Inc.	1	1	Sep 16, 2026	One time
Initiate Venture Partners Fund I, L.P.	Windham Venture Partners	1	1	Sep 16, 2026	One time
Braemar Energy Ventures	Windham Venture Partners	1	1	Sep 16, 2026	One time
Adjuvant Capital, LP	Windham Venture Partners	1	1	Sep 13, 2026	One time
Windham Venture Partners	Primer Management, LLC	1	1	Sep 16, 2026	One time

Relationships

Invested in (37)

→ rxware.ioCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ fore.bioCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ NebulaCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ NeusperaCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ NovocureCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ AytubioCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ PainteqCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ RevelleaestheticsCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ ScienceexchangeCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ SubjectWellCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ TailormedCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ UpwardhealthCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ ValerahealthCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ VergentbioCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ VytronusCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ WellDocCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ WillowCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ NeotractCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ Earlens CorpCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ Nuvaira, Inc.CompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ PersonalgenomeCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ AltoneuroscienceCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ AndrosCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ BlueprinthealthCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ CartivaCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ ChromaCode, Inc.CompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ AlconCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ ClevercarehealthplanCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ ControlradCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
→ CoravinCompanyPortfolio listing
Sep 13, 2026 to presentfactThe subject's own site
and 7 more

Employs (17)

→ Joe ProtoPersonCo-Founder
factThe subject's own site
→ Laura SagePersonDirector, Marketing & Investor Relations
factThe subject's own site
→ Ruth SegallPersonAssociate
factThe subject's own site
→ Kaylin CollinsPersonOperations Associate
factThe subject's own site
→ Jason HelgersonPersonOperating Partner
factThe subject's own site
→ Deneen VojtaPersonSenior Advisor
factThe subject's own site
→ Lorne TaichmanPersonDirector, Science & Technology
factThe subject's own site
→ Sterling SneadPersonAdvisor
factThe subject's own site
→ Allan BufferdPersonAdvisor
factThe subject's own site
→ Bill CrousePersonAdvisor
factThe subject's own site
→ Jeffrey SachsPersonAdvisor
factThe subject's own site
→ Sara VaezyPersonAdvisor
factThe subject's own site
→ David KereiakesPersonManaging Partner
factThe subject's own site
→ Adam FinePersonGeneral Partner & CEO
factThe subject's own site
→ Roger FinePersonChairman and Co-Founder
factThe subject's own site
→ Joseph I ProtoPersonMember
Jan 1, 2012 to presentfactForm ADV
→ Adam E FinePersonManaging Member
Mar 1, 2017 to presentfactForm ADV

Manages (9)

→ Windham Life Sciences Partners IV, L.P.FundInferred from principal
inferenceForm D
→ Windham-Mc Investment I, LLCFundVenture Capital Fund
Feb 14, 2019 to presentfactForm ADV
→ Windham Life Sciences Partners, L.P.FundVenture Capital Fund
Feb 14, 2019 to presentfactForm ADV
→ Windham Life Sciences Partners II, L.P.FundVenture Capital Fund
Feb 14, 2019 to presentfactForm ADV
→ Windham Life Sciences Partners III, L.P.FundVenture Capital Fund
Mar 30, 2020 to presentfactForm ADV
→ Windham-Gs Investment, LLCFundVenture Capital Fund
Mar 30, 2020 to presentfactForm ADV
→ Wlsp Coinvestment, LLCFundVenture Capital Fund
Mar 30, 2020 to presentfactForm ADV
→ Windham Life Sciences Partners II Annex Fund, L.P.FundVenture Capital Fund
Jul 13, 2022 to presentfactForm ADV
→ Windham-Crv Investment I, LLCFundVenture Capital Fund
Feb 14, 2019 to presentfactForm ADV

Owns (1)

← Ffpgp, LLCFirmMember
Mar 1, 2017 to presentfactForm ADV

Dated events

40 bookkeeping events (roster, classification and holdings changes) folded below

Show 40 bookkeeping events

First seen by DFX
Sep 17, 2026
date not stated
Earlens Corp no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Clevercarehealthplan no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Cureatr no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Coravin no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
INITIATE Ventures no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
MC10 no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Tailormed no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Vytronus no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
WellDoc no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Nuvaira, Inc. no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
SubjectWell no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Blueprinthealth no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
ChromaCode, Inc. no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Willow no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Neuspera no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Valerahealth no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Andros no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Glysens no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Painteq no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Cartiva no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Stryker no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Neotract no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Personalgenome no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Vergentbio no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Alcon no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Upwardhealth no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Controlrad no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Altoneuroscience no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Nebula no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Revelleaesthetics no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Scienceexchange no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Aytubio no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Dotscorp no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Novocure no longer listed on Windham Venture Partners's portfolio page
First seen by DFX
Sep 17, 2026
date not stated
Locemia no longer listed on Windham Venture Partners's portfolio page
Occurred
Jul 13, 2022
Windham Life Sciences Partners II Annex Fund, L.P. first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $12,357,343
Occurred
Jul 13, 2022
Windham-Gs Investment, LLC no longer reported on Form ADV by Windham Venture Partners
Occurred
Mar 31, 2021
Windham-Mc Investment I, LLC no longer reported on Form ADV by Windham Venture Partners
Occurred
Mar 30, 2020
Windham Life Sciences Partners III, L.P. first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $40,681,564
Occurred
Mar 30, 2020
Windham-Gs Investment, LLC first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $2,005,529

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 website (Form ADV), 1 work email (firm website) · as of 2026-09-17

Also named here, with no published line of their own (reach them through the firm): Joe Proto (Co-Founder), Laura Sage (Director, Marketing & Investor Relations), Ruth Segall (Associate), Kaylin Collins (Operations Associate), Jason Helgerson (Operating Partner), Deneen Vojta (Senior Advisor), Lorne Taichman (Director, Science & Technology), Sterling Snead (Advisor), Allan Bufferd (Advisor), Bill Crouse (Advisor), Jeffrey Sachs (Advisor), Sara Vaezy (Advisor).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:46541f13-5b07-48cb-966f-da73a652a6f2
First observed: Sep 12, 2026
Last observed: Sep 17, 2026 40 h ago
Source families: Federal regulator filings, Firm and issuer disclosures
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Windham Venture Partners

Venture Capital

New York, NY

We focus on advances in medical technology and digital health to change the face of healthcare.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:46541f13-5b07-48cb-966f-da73a652a6f2

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 12:29 AM UTC and rebuilt at most every 15 minutes.

Fund

Vintage

Lifecycle

Form D sold

GAV

LPs

Windham Life Sciences Partners IV, L.P.

2023

Fundraising

$30.8M

n/a

Windham Life Sciences Partners II Annex Fund, L.P.

2022

Active deployment

n/a

$7.5M

Windham Life Sciences Partners III, L.P.

2020

Mature

n/a

$55.6M

Wlsp Coinvestment, LLC

2020

Mature

n/a

$7.6M

Windham-Gs Investment, LLC

2020

Wound down

n/a

$2.0M

Windham-Mc Investment I, LLC

n/a

Wound down

n/a

$3.9M

Windham-Crv Investment I, LLC

n/a

Unknown

n/a

$2.3M

Windham Life Sciences Partners, L.P.

n/a

Unknown

n/a

$8.5M

Windham Life Sciences Partners II, L.P.

n/a

Unknown

n/a

$27.8M

Company

State

Stage

Round size

Partner

Attribution

Observed

fore.bio

n/a

Unknown

Sep 16, 2026

rxware.io

n/a

Unknown

Sep 16, 2026

Novocure

n/a

Unknown

Sep 13, 2026

Aytubio

n/a

Unknown

Sep 13, 2026

Painteq

n/a

Unknown

Sep 13, 2026

Altoneuroscience

n/a

Unknown

Sep 13, 2026

Andros

n/a

Unknown

Sep 13, 2026

Blueprinthealth

n/a

Unknown

Sep 13, 2026

Cartiva

n/a

Unknown

Sep 13, 2026

ChromaCode, Inc.

n/a

Unknown

Sep 13, 2026

Alcon

n/a

Unknown

Sep 13, 2026

Clevercarehealthplan

n/a

Unknown

Sep 13, 2026

Controlrad

n/a

Unknown

Sep 13, 2026

Coravin

n/a

Unknown

Sep 13, 2026

Cureatr

n/a

Unknown

Sep 13, 2026

INITIATE Ventures

n/a

Unknown

Sep 13, 2026

Dotscorp

n/a

Unknown

Sep 13, 2026

Glysens

n/a

Unknown

Sep 13, 2026

Stryker

n/a

Unknown

Sep 13, 2026

Locemia

n/a

Unknown

Sep 13, 2026

Mc10

n/a

Unknown

Sep 13, 2026

Nebula

n/a

Unknown

Sep 13, 2026

Neuspera

n/a

Unknown

Sep 13, 2026

Neotract

n/a

Unknown

Sep 13, 2026

Personalgenome

n/a

Unknown

Sep 13, 2026

Investor

Co-investor

Shared deals

Shared companies

Last observed

Strength

Asset Management Ventures, LLC

Windham Venture Partners

Sep 16, 2026

Recurring

Portfolia Venture Management, LLC

Windham Venture Partners

Sep 16, 2026

Recurring

Menlo Ventures

Windham Venture Partners

Sep 13, 2026

One time

Windham Venture Partners

Lightstone Ventures

Sep 13, 2026

One time

NEA: New Enterprise Associates

Windham Venture Partners

Sep 13, 2026

One time

Windham Venture Partners

Accelmed Partners II Management, LLC

Sep 16, 2026

One time

Windham Venture Partners

Riverwalk Capital

Sep 16, 2026

One time

Windham Venture Partners

Excel Venture Management

Sep 16, 2026

One time

Vivo Capital, LLC

Windham Venture Partners

Sep 16, 2026

One time

Windham Venture Partners

Union Square Ventures

Sep 16, 2026

One time

Windham Venture Partners

Mitsui & Co. Global Investment, Inc.

Sep 16, 2026

One time

Initiate Venture Partners Fund I, L.P.

Windham Venture Partners

Sep 16, 2026

One time

Braemar Energy Ventures

Windham Venture Partners

Sep 16, 2026

One time

Adjuvant Capital, LP

Windham Venture Partners

Sep 13, 2026

One time

Windham Venture Partners

Primer Management, LLC

Sep 16, 2026

One time